Chronic Administration of Mood Stabilizers Upregulates BDNF and Bcl-2 Expression Levels in Rat Frontal Cortex

This publication has 46 references indexed in Scilit:

• Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
  Molecular Psychiatry, 2008
• The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons
  Molecular Psychiatry, 2007
• RETRACTED: Chronic Administration of Carbamazepine Down-regulates AP-2 DNA-binding Activity and AP-2α Protein Expression in Rat Frontal Cortex
  Biological Psychiatry, 2007
• Brain-Derived Neurotrophic Factor Conditional Knockouts Show Gender Differences in Depression-Related Behaviors
  Biological Psychiatry, 2007
• BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan
  Gene Expression Patterns, 2006
• n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism
  Molecular Psychiatry, 2006
• Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex
  Molecular Psychiatry, 2006
• Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation
  Brain Research, 2006
• CREB Couples Neurotrophin Signals to Survival Messages
  Neuron, 2000
• Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities
  Proceedings of the National Academy of Sciences, 1999